GlassScriptPhysician profile
Erin N Moore
NPI 1134383854
$527.27
in general payments reported to CMS, 2019-2025
15 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2022: $77.11 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.97 · Education: $62.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.97 |
| Education | $62.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $89.35 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.44 | 2019-2025 | Synjardy |
| Lilly USA, LLC | $62.93 | 2019-2025 | Jardiance |
| Celgene Corporation | $46.72 | 2019 | |
| Abbvie INC. | $45.30 | 2019-2025 | |
| Amgen INC. | $39.51 | 2019-2025 | Repatha, Otezla |
| Hikma Pharmaceuticals USA | $30.12 | 2019 | |
| Novo Nordisk INC | $27.31 | 2019-2025 | Wegovy |
| Mallinckrodt Enterprises LLC | $26.78 | 2019 | |
| Amarin Pharma, INC. | $18.07 | 2019 | |
| Ucb, INC. | $16.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.48 | 2019 | |
| Merck Sharp & Dohme LLC | $13.39 | 2019 | |
| Pfizer INC. | $12.43 | 2019 | |
| Dynavax Technologies Corporation | $10.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.